Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1837 | 2393 | 33.9 | 59% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BRETAZENIL | Author keyword | 27 | 66% | 1% | 25 |
| 2 | ABECARNIL | Author keyword | 26 | 64% | 1% | 25 |
| 3 | FLUMAZENIL | Author keyword | 14 | 15% | 4% | 88 |
| 4 | PRECIPITATED ABSTINENCE | Author keyword | 11 | 100% | 0% | 6 |
| 5 | FG 7142 | Author keyword | 10 | 30% | 1% | 29 |
| 6 | IMIDAZENIL | Author keyword | 10 | 57% | 1% | 12 |
| 7 | BENZODIAZEPINE TOLERANCE | Author keyword | 9 | 67% | 0% | 8 |
| 8 | METHYL BETA CARBOLINE 3 CARBOXYLATE | Author keyword | 8 | 62% | 0% | 8 |
| 9 | BENZODIAZEPINE RECEPTOR | Author keyword | 7 | 14% | 2% | 50 |
| 10 | FLURAZEPAM | Author keyword | 7 | 32% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BRETAZENIL | 27 | 66% | 1% | 25 | Search BRETAZENIL | Search BRETAZENIL |
| 2 | ABECARNIL | 26 | 64% | 1% | 25 | Search ABECARNIL | Search ABECARNIL |
| 3 | FLUMAZENIL | 14 | 15% | 4% | 88 | Search FLUMAZENIL | Search FLUMAZENIL |
| 4 | PRECIPITATED ABSTINENCE | 11 | 100% | 0% | 6 | Search PRECIPITATED+ABSTINENCE | Search PRECIPITATED+ABSTINENCE |
| 5 | FG 7142 | 10 | 30% | 1% | 29 | Search FG+7142 | Search FG+7142 |
| 6 | IMIDAZENIL | 10 | 57% | 1% | 12 | Search IMIDAZENIL | Search IMIDAZENIL |
| 7 | BENZODIAZEPINE TOLERANCE | 9 | 67% | 0% | 8 | Search BENZODIAZEPINE+TOLERANCE | Search BENZODIAZEPINE+TOLERANCE |
| 8 | METHYL BETA CARBOLINE 3 CARBOXYLATE | 8 | 62% | 0% | 8 | Search METHYL+BETA+CARBOLINE+3+CARBOXYLATE | Search METHYL+BETA+CARBOLINE+3+CARBOXYLATE |
| 9 | BENZODIAZEPINE RECEPTOR | 7 | 14% | 2% | 50 | Search BENZODIAZEPINE+RECEPTOR | Search BENZODIAZEPINE+RECEPTOR |
| 10 | FLURAZEPAM | 7 | 32% | 1% | 18 | Search FLURAZEPAM | Search FLURAZEPAM |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RO 15 1788 | 35 | 30% | 4% | 96 |
| 2 | GABAERGIC SUBSENSITIVITY | 34 | 93% | 1% | 13 |
| 3 | FG 7142 | 32 | 56% | 2% | 39 |
| 4 | CHRONIC LORAZEPAM | 31 | 92% | 1% | 12 |
| 5 | GABA SENSITIVITY | 27 | 92% | 0% | 11 |
| 6 | CHRONIC BENZODIAZEPINE TREATMENT | 27 | 62% | 1% | 28 |
| 7 | BETA CARBOLINE ABECARNIL | 19 | 61% | 1% | 20 |
| 8 | CHRONIC DIAZEPAM | 18 | 83% | 0% | 10 |
| 9 | 3 LEVER PROCEDURE | 17 | 100% | 0% | 8 |
| 10 | N INDOL 3 YLGLYOXYLYLAMINO ACID DERIVATIVES | 17 | 100% | 0% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| NOVEL ANXIOLYTICS THAT ACT AS PARTIAL AGONISTS AT BENZODIAZEPINE RECEPTORS | 1990 | 255 | 17 | 59% |
| Benzodiazepines on trial: A research strategy for their rehabilitation | 1996 | 120 | 41 | 49% |
| Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond | 2008 | 44 | 191 | 32% |
| INTRINSIC ACTIONS OF THE BENZODIAZEPINE RECEPTOR ANTAGONIST RO-15-1788 | 1986 | 239 | 94 | 84% |
| GABA(A) receptor subtypes: any clues to the mechanism of benzodiazepine dependence? | 2005 | 60 | 47 | 36% |
| The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs | 1996 | 62 | 115 | 74% |
| Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal | 2002 | 103 | 236 | 28% |
| Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes | 2005 | 36 | 177 | 42% |
| RECENT DEVELOPMENTS IN THE BEHAVIORAL PHARMACOLOGY OF BENZODIAZEPINE-(OMEGA) RECEPTORS - EVIDENCE FOR THE FUNCTIONAL-SIGNIFICANCE OF RECEPTOR SUBTYPES | 1994 | 101 | 152 | 52% |
| The behavioral pharmacology of zolpidem: evidence for the functional significance of alpha 1-containing GABA(A) receptors | 2014 | 4 | 252 | 27% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CELLULAR MOL NEUROBIOL PROGRAM | 3 | 50% | 0.2% | 5 |
| 2 | PSYCHIAT BEHAV SCI BEHAV BIOL | 1 | 50% | 0.1% | 2 |
| 3 | CNRS FRE 2134 | 1 | 50% | 0.0% | 1 |
| 4 | EQUIPE GENET EPILEPSIES | 1 | 50% | 0.0% | 1 |
| 5 | MED BEHAV DEV MENTAL RETARDAT | 1 | 50% | 0.0% | 1 |
| 6 | NSDISCOVERY | 1 | 50% | 0.0% | 1 |
| 7 | PATGSP | 1 | 50% | 0.0% | 1 |
| 8 | PHARM PHARMACOL SHINAGAWA KU | 1 | 50% | 0.0% | 1 |
| 9 | PSYCHOL SCI S | 1 | 50% | 0.0% | 1 |
| 10 | SECT DEPENDENCY | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000172514 | GABAA RECEPTOR//SECT BIOCHEM PSYCHIAT//GABAA RECEPTORS |
| 3 | 0.0000123848 | ELEVATED PLUS MAZE//ONE TRIAL TOLERANCE//PLUS MAZE |
| 4 | 0.0000115153 | DIAZEPAM BINDING INHIBITOR//ACYL COA BINDING PROTEIN//OCTADECANEUROPEPTIDE |
| 5 | 0.0000099065 | DRUG DISCRIMINATION//NOVEL RESPONSE PROCEDURE//TRAINING DOSE |
| 6 | 0.0000096957 | ZOLPIDEM//ZOPICLONE//ZALEPLON |
| 7 | 0.0000085020 | LORAZEPAM//BROMAZEPAM//M EAMENTO CEREBRAL INTEGRACAO SENSORIO MOT |
| 8 | 0.0000079363 | ALKOXYCOUMARIN DEALKYLASE//PHENAZEPAM//GIDAZEPAM |
| 9 | 0.0000079117 | ROSS STUDIES NEURAL BIRTH DEFECTS//PRENATAL DIAZEPAM//NEUROBEHAVIORAL TERATOGENICITY |
| 10 | 0.0000075241 | MOTOR SEIZURES//MED 3 PATHOPHYSIOL//POSTSYNAPTIC ELEMENT |